Chemoinformaics analysis of Inerminoside C heptaacetate
| Molecular Weight | 968.952 | nRot | 21 |
| Heavy Atom Molecular Weight | 908.472 | nRig | 32 |
| Exact Molecular Weight | 968.353 | nRing | 4 |
| Solubility: LogS | -4.025 | nHRing | 3 |
| Solubility: LogP | 2.978 | No. of Aliphatic Rings | 4 |
| Acid Count | 1 | No. of Aromatic Rings | 0 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 1 |
| Atoms Count | 128 | No. of Aliphatic Hetero Cycles | 3 |
| No. of Heavy Atom | 68 | No. of Aromatic Carbocycles | 0 |
| nHetero | 23 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 0 | No. Saturated Carbocycles | 1 |
| No. of Hydrogen atom | 60 | No. of Saturated Hetero Cycles | 2 |
| No. of Carbon atom | 45 | No. of Saturated Rings | 3 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 0 |
| No. of Oxygen atom | 23 | No. of Arom Bond | 0 |
| nHA | 22 | APOL | 133.604 |
| nHD | 1 | BPOL | 90.5724 |
| QED | 0.075 |
| Synth | 6.217 |
| Natural Product Likeliness | 2.111 |
| NR-PPAR-gamma | 0.03 |
| Lipinski | Rejected |
| Pfizer | Accepted |
| GSK | Rejected |
| Golden Triangle | Rejected |
| Pgp-inh | 0.01 |
| Pgp-sub | 0.841 |
| HIA | 0.921 |
| CACO-2 | -5.38 |
| MDCK | 0.000458034 |
| BBB | 0.081 |
| PPB | 0.34589 |
| VDSS | 1.209 |
| FU | 0.233288 |
| CYP1A2-inh | 0.003 |
| CYP1A2-sub | 0.005 |
| CYP2c19-inh | 0.013 |
| CYP2c19-sub | 0.046 |
| CYP2c9-inh | 0.017 |
| CYP2c9-sub | 0.002 |
| CYP2d6-inh | 0.919 |
| CYP2d6-sub | 0.011 |
| CYP3a4-inh | 0.333 |
| CYP3a4-sub | 0.258 |
| CL | 1.861 |
| T12 | 0.312 |
| hERG | 0.091 |
| Ames | 0.329 |
| ROA | 0.061 |
| SkinSen | 0.853 |
| Carcinogencity | 0.178 |
| EI | 0.039 |
| Respiratory | 0.686 |
| NR-Aromatase | 0.015 |
| Antiviral | Yes |
| Prediction | 0.516816 |